I completely agree about Broadfin! They have not impressed me whatsoever. With the Nasdaq delisting notice closing in, no real market value, and a company that lacks to put out PRs and keep shareholders updated, it's hard to see this stock being any more than a huge gamble. I would like to know why Wedbush feels this is a buy.
I still take a contrarian look at this stock for the positive (or try to).
I understand your reason for being frustrated. Cardica has ran around circles for 15 years and has very little revenue to show for it. There's no telling what's going on but I guess I'm hoping that something will come of this.
Is there any way to validate the truthfulness of the insider buying reply that was made? Is Cardica under threat of getting delisting or can they file for a six month extension or something?
Too many umms and uhs from the conversation with the CFO. I don't like that and never have. The other member I spoke to...he was using some inappropriate language...correction though, he was from Broadfin but I don't think he is on the board.
If they nail this, they're not going at it alone. They already receive small license and development revenue from Intuitive Surgical (ISRG).
I've made many mistakes in the past. I've been irritated by the way the management at Cardica has communicated with shareholders and how their website looks like it was built in the mid to early 90s.
With that said, I'm taking a risk while the prices are low and while you all are selling some of your shares, I'm starting to buy some up. The problem I have is I feel like there has been so much downward pressure put on this stock compared to the upward potential, that it is worth a shot.
I really liked how the questions on the Quarterly meeting were aimed at the guts of Cardica management. Hey guys, why aren't there are insider transactions right now if Cardica is such a great buy? Hey guys, when are you going to put your focus on building shareholder value? And Kevin from Broadfin who was the final question asker...I'm not so sure about him...just a gut feeling on my end.
It's obvious all the negatives for this stock and I feel them too. Here are the positives I see: 1. With the layoffs, the cash burn rate is significantly lower and there should be no reason to have to dilute shareholder value in the near future with releasing more shares. 2. These guys have already built a reputation with a lot of these hospitals/surgeons and there is a ton of positive feedback. It's just a matter of getting the product out there where the surgeons can access it. 3. The market size for the Microcutters is huge. There's big profit potential. 4. With a say, 120 day turnaround from the FDA, a commercial launch, expanded vascular capabilities, I'm pretty happy.
All in all, I feel like the pain that has been inflicted on this stock is at one of its highest points...could be right, could definitely be wrong. I've talked to the CFO, I've even talked to a member of Board - I have mixed feelings about the conversations I have had with them. I'm a bit more impressed with a little more transparency lately with the Business Update meeting. But, why not issue more PRs? Drives me nuts!
Tickedoffinvestor - are you the Jay Gershman from Retirement Vision LLC? If so, I'd be a little more careful on how you treat and talk to people. You'd be very surprised who knows who in the grand scheme of things and how bad morale can spread like wild fire.
Kevin may not be a member of the board...so you may be right there. However, he is with Broadfin and his contact information is included in a couple press releases. I'm ready to see the company move in a positive direction, just not sure that Cardica wasn't moving in that direction anyways.
What makes the valuation of this stock any less than what it was before? I think just the uncertainty of Japan but more importantly the timing of the commercial and public launch of the Microcutter product. Any information from management on the prospective timing of a commercial launch of the product and I can't see how this stock can't show some better valuation. They could at least put how a PR with an ETA even if it is broad like Summer of Fall of 2015...
My only concern is I hope Broadfin is on the board for the right reasons and not to just scrape a breakeven point. You can never tell and you unfortunately have to take a contrarian view...
Let's just say it was the most important board member from a Broadfin perspective. I find cussing at me and telling me he's just calling me as a matter of courtesy to be very rude and unprofessional. Further, if he doesn't want to be called then don't list your name on the investment contacts on the PRs. Lastly, this board member checks the Yahoo message board because he was irritated by one of my posts. He also made some choice comments about the posts of gene_ramirez_vox.
I am a pretty transparent person and they're not going to like it when they read this but then they need to step up to the plate as the board and lead the company by example and treat their shareholders with respect.
Shareholders like me, it is my strong opinion that each and every one of you should contact the board of directors and CFO by telephone and let them know your dissatisfaction with the way the company as a whole is not communicating to shareholders. They need to make public their plans to have a commercial launch of Microcutter and their projected timelines for doing so. Please agree with me and do your due diligence to call these people. Enough people who let them know you are displeased with their lack of communication, maybe the more traction we can get toward real world action here...
Additionally, the new board members from Broadfin need to know they are on a trial only basis and that we as shareholders will vote each and every one of them out at the next proxy if they do not make swift actions to make something of what they have done to the current board. If you're going to rip three people off the board, you better bring about some real world action and let's hold them highly accountable for their actions.
They need to get a PR out updating us on the status of the Microcutter and what plans are moving forward to getting it to commercial launch. My advice to you is to contact with three new people on Broadfin's board (info to contact is in a PR) and the CFO of Cardica (on website). This is what I did. I'm not impressed with the attitude of one of the board members as he used cuss words on the phone because he was irritated at me, but I'll leave it at that. At this point, most are probably going to be selling to take their year end loss unless Cardica does something smart like keeping their shareholders in the loop.
A few more comments about what was mentioned above: My understanding is the product was pulled for improvement purposes only and that the next step could potentially be a commercial launch. I also interpret from my conversation that having the doctors/hospitals already using the microcutter and letting them utilize it first and provide initial feedback has added to the potential credibility for the company. Additionally, there is no government / regulatory approvals to jump through when commercially launching this product. Again, these statements are only my interpretations from the conversation I had with an employee of Cardica.
Lastly, as shareholders I think it is important that to realize that Cardica is going to bat with the likes of Johnson & Johnson and Medtronix and that the implications for a huge success are hopeful. Again, my big concern is timing for launch and who / how they launch this product to insure more cash flow, future profitability, and potentially a buyout if large companies see this as the cutting edge market penetrating technology that it truly has the potential to be. The buyout prospect idea is something I threw out there and is probably not that likely for quite some time in my opinion as they have to prove that they are worthy to be in the industry and that they can generate revenue and sales.
You bet. I will post more to this thread to try and simplify anything I think will help us in continual valuation for this company and I hope you will hope me do the same.
I just talked to someone with Cardica. The product pull is not due to failure of any regulatory requirements. Secondly, Japan is still pending and the pull of the product has no impact on the pending decision from Japan.
The big problem here is they need to generate revenue. The positive is they have $38 million and with current burn rate they should not need to dilute the stock in the near future.
The management and board have been on vacation for the last two years...it's time to put out or GET OUT. That goes for every member of management and the entire board. Let's hold them accountable. If you care about the future of the company and your stock price as a shareholder, start calling Cardica CFO daily - Bob Newell - 650-331-7133. If you were taking his money, he'd be calling you so he can start providing us as shareholders with more information.
NO response yet from Cardica! While their upper management continues to get slammed with stock options, they still give us no profit, no sign of profit for the future, and no guidance on their product. All of the entire board needs to be held liable too...it's time for Broadfin to influence this company so I hope their board members have the business acumen to help Cardica. At this point, nothing impresses me. So, again I call out the CFO, return my phone call and stop ignoring it. You know good and well there are questions you can answer that are investor information that are not secrets. Cardica - Your website is out of date...fix it...will you ever release your product again? Your shareholders surely would like to know.
If you visit Broadfin Capital's website, it takes you to a login for the site. There is no further information for some of what looks like stock art of 3-4 surgeons. However with that aside, you have to think they have a vested interest in increasing the value of the company stock because they own over 17% of it. Could they afford to increase their position in the company? OF COURSE...compared to the companies they hold in dollars of value, they should buy more shares and dollar cost average. Will they? I guess that depends on how confident they are in the company's future now that they have 3 board positions.
Kevin Kotler...take over this company...the technology is great but only lasts until others in the field beat this company to the punch. Buy the heck out of the shares and show us little shareholders what it feels like to pick a winner.
All the hype of the bashers on this board trying to lower the price of this stock so they can buy more on low prices is ridiculous. It is not unusual for the FDA to postpone a decision for 3 months so that "i"s can be dotted and "t"s crossed. If anything, it is a good sign in my opinion that they have put off the decision to approve it for 3 more months.
It has allowed me to buy in for cheap and I'll ride it back up to $6.50-6.75 or more. The good news is the FDA did not crush the NDA that was submitted. The fact that they took all this time in reviewing the data as a whole including the safety as well as the results as compared to the endpoints as related to the goals and did not reject the drug, is an extremely positive sign to me.
Just my opinion - do your own research and don't give these bashers your stock for dirt cheap because they are buying it up low as you sell on the cheap. Otherwise, tomorrow you may wake up and wonder what happened when you could have gained hundreds or thousands and the buying bashers win....FORGET THAT!!!